<DOC>
	<DOC>NCT00407017</DOC>
	<brief_summary>The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.</brief_summary>
	<brief_title>Therapeutic Variables in Cataract Surgery</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Nepafenac</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Gatifloxacin</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Males or females scheduled to undergo cataract surgery Patients can be receiving monofocal IOLs only Likely to complete all study visits and able to provide informed consent Visual potential of 20/25 or better Known contraindications to any study medication or ingredients Active ocular diseases or uncontrolled systemic disease Active ocular allergies</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>